Generic Drug

(Image: Getty/marchmeena29)

Amneal invests $340m in generics distributor

By Vassia Barba

Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.

(Image: Getty/Thida Ratn Caem Caeng  EyeEm)

Q&A

2018: An inflection point for generics

By Flora Southey

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers